These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 11577546)
21. Therapeutic applications of antiflammin peptides in experimental ocular inflammation. Chan CC; Tuaillon N; Li Q; Shen DF Ann N Y Acad Sci; 2000; 923():141-6. PubMed ID: 11193752 [TBL] [Abstract][Full Text] [Related]
22. Allergic and immunologic disorders of the eye. Part I: immunology of the eye. Bielory L J Allergy Clin Immunol; 2000 Nov; 106(5):805-16. PubMed ID: 11080700 [TBL] [Abstract][Full Text] [Related]
23. Nerve growth factor involvement in the visual system: implications in allergic and neurodegenerative diseases. Micera A; Lambiase A; Aloe L; Bonini S; Levi-Schaffer F; Bonini S Cytokine Growth Factor Rev; 2004 Dec; 15(6):411-7. PubMed ID: 15561599 [TBL] [Abstract][Full Text] [Related]
24. Immunologic aspects of diseases of the eye. Friedlaender MH JAMA; 1992 Nov; 268(20):2869-73. PubMed ID: 1433702 [No Abstract] [Full Text] [Related]
25. Allergic disorders of the eye. Easty DL Practitioner; 1978 Apr; 220(1318):581-90. PubMed ID: 652696 [No Abstract] [Full Text] [Related]
26. Allergic disorders of the anterior segment. Richmond PP; Allansmith MR Int Ophthalmol Clin; 1983; 23(1):43-61. PubMed ID: 6826303 [No Abstract] [Full Text] [Related]
27. Future directions in therapeutic interventions for conjunctival inflammatory disorders. Pflugfelder SC; Stern ME Curr Opin Allergy Clin Immunol; 2007 Oct; 7(5):450-3. PubMed ID: 17873588 [TBL] [Abstract][Full Text] [Related]
28. [Epidemiology of allergic eye diseases]. Bogacka E Pol Merkur Lekarski; 2003 Jun; 14(84):714-5. PubMed ID: 14524314 [TBL] [Abstract][Full Text] [Related]
35. Transcriptional analyses before and after suppression of immediate hypersensitivity reactions by CCR3 blockade in eyes with experimental allergic conjunctivitis. Komatsu N; Miyazaki D; Tominaga T; Kuo CH; Namba S; Takeda S; Higashi H; Inoue Y Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5307-13. PubMed ID: 18658092 [TBL] [Abstract][Full Text] [Related]
36. Ocular mast cells. Characterization in normal and disease states. Cook EB; Stahl JL; Barney NP; Graziano FM Clin Rev Allergy Immunol; 2001 Apr; 20(2):243-68. PubMed ID: 11349612 [No Abstract] [Full Text] [Related]
37. Immune mechanisms in allergic eye diseases: what is new? Offiah I; Calder VL Curr Opin Allergy Clin Immunol; 2009 Oct; 9(5):477-81. PubMed ID: 19620858 [TBL] [Abstract][Full Text] [Related]
38. Epithelial ICAM-1 regulation and its role in allergy. Papi A Clin Exp Allergy; 1997 Jul; 27(7):721-4. PubMed ID: 9249263 [No Abstract] [Full Text] [Related]
39. Pediatric ocular inflammation. Wagner RS; Aquino M Immunol Allergy Clin North Am; 2008 Feb; 28(1):169-88, vii. PubMed ID: 18282551 [TBL] [Abstract][Full Text] [Related]
40. [Lymphoblastic transformation test in diagnosis of ophthalmologic allergic disorders of bacterial etiology]. Halpern G Bull Soc Ophtalmol Fr; 1970 Dec; 70(12):1175-83. PubMed ID: 5526386 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]